COX-1, COX-2 and CYP2C19 variations may be related to cardiovascular events due to acetylsalicylic acid resistance.
Deniz KiracAysun Erdem YamanTansu DoranMujgan MihmanliElif Çiğdem KasparPublished in: Molecular biology reports (2022)
COX-1 and COX-2 gene mutations may increase the risk of CE due to AR whereas CYP2C19*17 may have a protective effect in this process.